Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Denali Therapeutics (DNLI)
NASDAQ:DNLI
Denali Therapeutics (DNLI) Ownership - Who Owns Denali Therapeutics?
597 Followers
Denali Therapeutics (DNLI) Ownership Overview
38.97% Insiders
28.86% Mutual Funds
15.15% Other Institutional Investors
17.02% Public Companies and Individual Investors
The ownership structure of Denali Therapeutics (DNLI) stock is a mix of institutional, retail and individual investors. Approximately 44.01% of the company’s stock is owned by Institutional Investors, 38.97% is owned by Insiders and 17.02% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 03, 2024 | Steve E. Krognes Director | xxxxxxxxxxxxx | $14992 |
| Feb 15, 2024 | Steve E. Krognes Director | xxxxxxxxxxxxx | $47548 |
| Feb 15, 2024 | Ryan J. Watts President & Ceo,director | xxxxxxxxxxxxx | $165794 |
| Feb 15, 2024 | Alexander O. Schuth Cofo And Secretary | xxxxxxxxxxxxx | $46960 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $9627347 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $10435753 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $24065548 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $27999868 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,615,042 | Institution | 7.44% | 227,798,801 | |
| 9,263,721 | Institution | 6.50% | 198,799,453 | |
| 7,674,724 | Institution | 5.38% | 164,699,577 | |
| 6,213,566 | Institution | 4.36% | 133,343,126 | |
| 4,269,259 | Institution | 2.99% | 91,618,298 | |
| 3,885,514 | Institution | 2.72% | 83,383,130 | |
| 3,731,695 | Institution | 2.62% | 80,082,175 | |
| 1,721,278 | Institution | 1.21% | 36,938,626 | |
| 1,364,516 | Institution | 0.96% | 29,282,513 | |
| 1,260,371 | Institution | 0.88% | 27,047,562 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,263,721 | Institution | 6.50% | 198,799,453 | |
| 7,674,724 | Institution | 5.38% | 164,699,577 | |
| 4,269,259 | Institution | 2.99% | 91,618,298 | |
| 3,885,514 | Institution | 2.72% | 83,383,130 | |
| 1,260,371 | Institution | 0.88% | 27,047,562 | |
| 1,225,681 | Institution | 0.86% | 26,303,114 | |
| 1,197,891 | Institution | 0.84% | 25,706,741 | |
| 1,141,800 | Institution | 0.80% | 24,503,028 | |
| 1,020,500 | Institution | 0.72% | 21,899,930 | |
| 937,262 | Institution | 0.66% | 20,113,643 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,491,006 | Institution | 2.45% | 81,061,159 | |
| 3,296,258 | Institution | 2.31% | 70,737,697 | |
| 2,688,379 | Institution | 1.89% | 62,424,160 | |
| 1,924,179 | Institution | 1.35% | 44,679,436 | |
| 1,514,491 | Institution | 1.06% | 35,166,481 | |
| 1,556,811 | Institution | 1.09% | 33,907,344 | |
| 867,653 | Institution | 0.61% | 18,619,833 | |
| 638,385 | Institution | 0.45% | 13,699,742 | |
| 607,862 | Institution | 0.43% | 13,239,234 | |
| 462,774 | Institution | 0.32% | 10,745,612 |
FAQ
Who Owns Denali Therapeutics (DNLI)?
According to the latest TipRanks data, approximately 15.15% of the company's stock is held by institutional investors, 38.97% is held by insiders, and 17.02% is held by retail investors.
What percentage of Denali Therapeutics (DNLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 15.15% of Denali Therapeutics (DNLI) stock is held by institutional investors.
What percentage of Denali Therapeutics (DNLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 17.02% of Denali Therapeutics (DNLI) stock is held by retail investors.
Who owns the most shares of Denali Therapeutics (DNLI)?
Vanguard owns the most shares of Denali Therapeutics (DNLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.